|Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer|
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
|GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer|
PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ...
Nature genetics 45 (4), 362-370, 2013
|Identification of six new susceptibility loci for invasive epithelial ovarian cancer|
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
|MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+ CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition|
D Chen, Y Zhang, J Wang, J Chen, C Yang, K Cai, X Wang, F Shi, J Dou
Journal of ovarian research 6 (1), 1-11, 2013
|Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer|
H Shen, BL Fridley, H Song, K Lawrenson, JM Cunningham, SJ Ramus, ...
Nature communications 4 (1), 1-10, 2013
|Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome|
I Kalogiannidis, S Lambrechts, F Amant, P Neven, T Van Gorp, I Vergote
American journal of obstetrics and gynecology 196 (3), 248. e1-248. e8, 2007
|HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer|
AE Teschendorff, SH Lee, A Jones, H Fiegl, M Kalwa, W Wagner, ...
Genome medicine 7 (1), 1-12, 2015
|Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21. 31|
J Permuth-Wey, K Lawrenson, HC Shen, A Velkova, JP Tyrer, Z Chen, ...
Nature communications 4 (1), 1-12, 2013
|Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium|
CM Nagle, SC Dixon, A Jensen, SK Kjaer, F Modugno, A DeFazio, ...
British journal of cancer 113 (5), 817-826, 2015
|ABCA transporter gene expression and poor outcome in epithelial ovarian cancer|
EL Hedditch, B Gao, AJ Russell, Y Lu, C Emmanuel, J Beesley, ...
JNCI: Journal of the National Cancer Institute 106 (7), 2014
|The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment|
E Despierre, D Lambrechts, P Neven, F Amant, S Lambrechts, I Vergote
Gynecologic oncology 117 (2), 358-365, 2010
|Genome-wide significant risk associations for mucinous ovarian carcinoma|
LE Kelemen, K Lawrenson, J Tyrer, Q Li, JM Lee, JH Seo, CM Phelan, ...
Nature genetics 47 (8), 888, 2015
|BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients–a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD)|
I Ruscito, D Dimitrova, I Vasconcelos, K Gellhaus, T Schwachula, F Bellati, ...
European journal of cancer 50 (12), 2090-2098, 2014
|Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy|
E Despierre, S Lambrechts, K Leunen, P Berteloot, P Neven, F Amant, ...
Gynecologic oncology 130 (1), 192-199, 2013
|Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients-a study of the OVCAD consortium|
A Bachmayr-Heyda, S Aust, G Heinze, S Polterauer, C Grimm, EI Braicu, ...
BMC cancer 13 (1), 422, 2013
|ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas|
SE Johnatty, J Beesley, B Gao, X Chen, Y Lu, MH Law, MJ Henderson, ...
Gynecologic oncology 131 (1), 8-14, 2013
|Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers|
J Beesley, HA Pickett, SE Johnatty, AM Dunning, X Chen, J Li, ...
PloS one 6 (9), e24987, 2011
|Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study|
SC Dixon, CM Nagle, AP Thrift, PDP Pharoah, CL Pearce, W Zheng, ...
International journal of epidemiology 45 (3), 884-895, 2016
|Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients–A study of the OVCAD consortium|
D Pils, A Bachmayr-Heyda, K Auer, M Svoboda, V Auner, G Hager, ...
European journal of cancer 50 (1), 99-110, 2014
|Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium|
F Trillsch, L Woelber, C Eulenburg, I Braicu, S Lambrechts, R Chekerov, ...
Journal of ovarian research 6 (1), 42, 2013